EP Patent

EP1796689A4 — GEMCITABINE FREE OR ENCAPSULATED IN LIPOSOMES ONLY OR IN ASSOCIATION WITH FREE IDARUBICIN OR ENCAPSULATED IN LIPOSOMES

Assigned to British Columbia Cancer Agency BCCA · Expires 2009-01-14 · 17y expired

What this patent protects

Patent listed against Cytarabine.

Drugs covered by this patent

Patent Metadata

Patent number
EP1796689A4
Jurisdiction
EP
Classification
—
Expires
2009-01-14
Drug substance claim
No
Drug product claim
No
Assignee
British Columbia Cancer Agency BCCA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.